Comprehensive Analysis of Cetuximab Critical Quality Attributes: Impact of Handling on Antigen-Antibody Binding

• Príomhchruthaitheoirí: Alicia Torres-García (Údar), Anabel Torrente-López (Údar), Jesús Hermosilla (Údar), Amparo Hernández (Údar), Antonio Salmerón-García (Údar), José Cabeza (Údar), Natalia Navas (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2024-09-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background/Objectives: Cetuximab, formulated in Erbitux^® (5 mg/mL), is a therapeutic monoclonal antibody (mAb) widely used in several cancer treatments. Currently, there is insufficient knowledge about the behavior of cetuximab with regard to the risk associated with its routi...